In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris

被引：9

作者：

Herrada, Janet ^{[1
,2
]}

Gamal, Ahmed ^{[1
,2
]}

Long, Lisa ^{[1
,2
]}

Sanchez, Sonia P. ^{[3
]}

McCormick, Thomas S. ^{[1
,2
]}

Ghannoum, Mahmoud A. ^{[1
,2
]}

机构：

[1] Univ Hosp Cleveland, Med Ctr, Ctr Med Mycol, Cleveland, OH 44106 USA

[2] Case Western Reserve Univ, Cleveland, OH 44106 USA

[3] Gilead Sci Europe Ltd, Uxbridge, Middx, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2021年 / 65卷 / 06期

基金：

美国国家卫生研究院;

关键词：

Candida auris; multidrug resistant; AmBisome; conventional amphotericin B; fluconazole; susceptibility testing; mouse models; CLONAL STRAIN; NEW-YORK; SUSCEPTIBILITY; FORMULATIONS; RESISTANT; EFFICACY;

D O I：

10.1128/AAC.00306-21

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Antifungal activity of AmBisome against Candida auris was determined in vitro and in vivo. AmBisome showed MIC50 and MIC90 values of 1 and 2 mu g/ml, respectively. Unlike conventional amphotericin B, significant in vivo efficacy was observed in the AmBisome 7.5mg/kg treatment group in survival and reduction of kidney tissue fungal burden compared to the untreated group. Our data show that AmBisome has significant antifungal activity against C. auris infection in vitro and in vivo.

引用

页数：4

共 21 条

[1] Candida auris in Healthcare Facilities, New York, USA, 2013-2017
Adams, Eleanor
Quinn, Monica
Tsay, Sharon
Poirot, Eugenie
Chaturvedi, Sudha
Southwick, Karen
Greenko, Jane
Fernandez, Rafael
Kallen, Alex
Vallabhaneni, Snigdha
Haley, Valerie
Hutton, Brad
Blog, Debra
Lutterloh, Emily
Zucker, Howard
[J]. EMERGING INFECTIOUS DISEASES, 2018, 24 (10) : 1816 - 1824
[2] Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
Adler-Moore, Jill
Lewis, Russell E.
Bruggemann, Roger J. M.
Rijnders, Bart J. A.
Groll, Andreas H.
Walsh, Thomas J.
[J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 : S244 - S259
[3] Multidrug-resistant endemic clonal strain of Candida auris in India
Chowdhary, A.
Kumar, V. Anil
Sharma, C.
Prakash, A.
Agarwal, K.
Babu, R.
Dinesh, K. R.
Karim, S.
Singh, S. K.
Hagen, F.
Meis, J. F.
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (06) : 919 - 926
[4] New Clonal Strain of Candida auris, Delhi, India
Chowdhary, Anuradha
Sharma, Cheshta
Duggal, Shalini
Agarwal, Kshitij
Prakash, Anupam
Singh, Pradeep Kumar
Jain, Sarika
Kathuria, Shallu
Randhawa, Harbans S.
Hagen, Ferry
Meis, Jacques F.
[J]. EMERGING INFECTIOUS DISEASES, 2013, 19 (10) : 1670 - 1673
[5] Clinical and Laboratory Standards Institute, 2017, M27A4 CLSI
[6] Candida auris Candidemia in Kuwait, 2014
Emara, Maha
Ahmad, Suhail
Khan, Ziauddin
Joseph, Leena
Al-Obaid, Ina'm
Purohit, Prashant
Bafna, Ritu
[J]. EMERGING INFECTIOUS DISEASES, 2015, 21 (06) : 1091 - 1092
[7] Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Faustino, Celia
Pinheiro, Lidia
[J]. PHARMACEUTICS, 2020, 12 (01)
[8] Candida auris: The recent emergence of a multidrug-resistant fungal pathogen
Forsberg, Kaitlin
Woodworth, Kate
Walters, Maroya
Berkow, Elizabeth L.
Jackson, Brendan
Chiller, Tom
Vallabhaneni, Snigdha
[J]. MEDICAL MYCOLOGY, 2019, 57 (01) : 1 - 12
[9] Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection
Fujimoto, Koichi
Takemoto, Koji
[J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (12) : 958 - 964
[10] Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model
Hager, Christopher L.
Larkin, Emily L.
Long, Lisa A.
Ghannoum, Mahmoud A.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (08) : 2085 - 2088

← 1 2 3 →